NEW YORK, June 30 - Milan-based biotech firm Axxam has licensed Spotfire's DecisionSite software, Spotfire said today.
Axxam is using an application based on Spotfire's DecisionSite for Lead Discovery software to analyze data produced by Molecular Devices' FLIPR (Fluorometric Imaging Plate Reader) system, Spotfire said.
Axxam is also using DecisionSite for Functional Genomics to discover and validate new genomic targets.